Trial · NCT01505764
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Body Potassium. | Arm 1 (Anamorelin HCl) | -2.13 | Standard Deviation 5.48 | percentage change | |
| Total Body Potassium. | Arm 2 (Placebo) | -0.72 | Standard Deviation 2.11 | percentage change | |
| Lean Mass Measured by Densitometry. | Arm 1 (Anamorelin HCl) | 2.12 | Standard Deviation 3.05 | percentage change | |
| Lean Mass Measured by Densitometry. | Arm 2 (Placebo) | -1.44 | Standard Deviation 0.5 | percentage change | |
| Muscle Strength as Measured by Grip Strength. | Arm 1 (Anamorelin HCl) | 0.31 | Standard Deviation 11.19 | percentage change | |
| Muscle Strength as Measured by Grip Strength. | Arm 2 (Placebo) | -10.45 | Standard Deviation 14.49 | percentage change | |
| Body Weight. | Arm 1 (Anamorelin HCl) | 1.7 | Standard Deviation 3.19 | percentage change | |
| Body Weight. | Arm 2 (Placebo) | -1.8 | Standard Deviation 0.07 | percentage change | |
| Quality of Life. | Arm 1 (Anamorelin HCl) | -6.54 | Standard Deviation 4.9 | percentage change | |
| Quality of Life. | Arm 2 (Placebo) | -14.32 | Standard Deviation 3.78 | percentage change | |
| Appetite. | Arm 1 (Anamorelin HCl) | 8.33 | Standard Deviation 38.18 | percentage change | |
| Appetite. | Arm 2 (Placebo) | 1.66 | Standard Deviation 25.92 | percentage change | |
| Resting Energy Expenditure. | Arm 1 (Anamorelin HCl) | -1.02 | Standard Deviation 13.8 | percentage change | |
| Resting Energy Expenditure. | Arm 2 (Placebo) | -2.58 | Standard Deviation 2.75 | percentage change | |
| Functional Performance. | Arm 1 (Anamorelin HCl) | 22.53 | Standard Deviation 9.87 | percentage change | |
| Functional Performance. | Arm 2 (Placebo) | -13.8 | Standard Deviation 12.36 | percentage change | |
| Body Composition. | Arm 1 (Anamorelin HCl) | -5.7 | Standard Deviation 3.4 | percentage change | |
| Body Composition. | Arm 2 (Placebo) | 6.31 | Standard Deviation 4.2 | percentage change | |
| Stair Climbing Power | Arm 1 (Anamorelin HCl) | -30.39 | Standard Deviation 27.86 | percentage change | |
| Stair Climbing Power | Arm 2 (Placebo) | 4.12 | Standard Deviation 15.23 | percentage change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01505764/results